Drug distributor McKesson missed estimates for third-quarter revenue on Wednesday, hurt by less-than-expected sales in its ...
McKesson Corp. and AmerisourceBergen Drug Corp. are among the drug distributors that won a bid to toss antitrust claims that they colluded to inflate prices of several generic pharmaceutical products.
Irving-based McKesson (NYSE: MCK) announced on Feb. 4 an agreement to buy an 80% controlling interest in New Providence, New ...
Shares of McKesson Corp. MCK slipped 1.63% to $594.75 Friday, on what proved to be an all-around rough trading session for ...
Learn more about whether Encompass Health Corporation or McKesson Corporation is a better investment based on AAII's A+ ...
McKesson Corporation has signed a definitive agreement to acquire an 80% stake in Prism Vision Holdings from Quad-C for approximately $850 million.
McKesson Corp. closed 5.19% below its 52-week high of $637.51, which the company reached on August 2nd.
Based on our third quarter performance, we are raising and narrowing our guidance range for fiscal 2025 Adjusted Earnings per Diluted Share to $32.55 to $32.95. We are also pleased to announce the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results